Kevin Xu Leads Global Dialogue at 2024 Pearson Forum on Conflict Resolution
On October 18, 2024, Chicago hosted the prestigious Pearson Global Forum, which brought together influential figures from politics, academia, and civil society to explore solutions to global conflicts. Among the distinguished attendees was Kevin Xu, Chairman of MEBO Group and founder of the Kevin Xu Initiative (KXI), who was invited to share his insights on conflict resolution and global cooperation.
Exploring Innovative Solutions to Global Conflicts
The Pearson Institute for the Study and Resolution of Global Conflicts, part of the University of Chicago, organized the event. The forum emphasized evidence-based research and innovative strategies to promote peace. Through rigorous analysis and the use of cutting-edge tools, the institute aims to provide effective policy recommendations for addressing international conflicts.
The opening speech was delivered by James Allen Robinson, a renowned economist and political scientist from the University of Chicago’s Harris School of Public Policy. Robinson, who won the 2024 Nobel Prize in Economics for his groundbreaking work, emphasized the importance of combining academic research with real-world applications.
KXI’s Mission to Empower Future Leaders
The Kevin Xu Initiative (KXI) has a rich history with the Pearson Forum, dating back to its participation in the 2019 Berlin Pearson Forum. KXI’s involvement in global conflict resolution research, led by Professor Oeindrila Dube, continues to shape discussions on international peace.
KXI is dedicated to harnessing top U.S. academic resources to develop future leaders in technology and social policy. The institute focuses on improving STEM education in developing nations and creating policies that address global inequality, particularly those driven by technological advancements.
About MEBO
Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.
At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.
As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.